SNCAIP and Parkinson disease: Synphilin-1 can reduce PD-linked mutant alpha-synuclein-, rotenone-, and 6-HODA-induced toxicity in vitro and delays alpha-synucleinopathies in a PD mouse model in vivo [7], [8].